cgp 52411 has been researched along with Breast Neoplasms in 2 studies
4,5-dianilinophthalimide: structure given in first source
4,5-dianilinophthalimide : Phthalimide substituted at the 4- and 5-positions by anilino groups.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, M | 1 |
| Patel, NA | 1 |
| Taggart, J | 1 |
| Sridhar, R | 1 |
| Cooper, DR | 1 |
| Lichtner, RB | 1 |
| Menrad, A | 1 |
| Sommer, A | 1 |
| Klar, U | 1 |
| Schneider, MR | 1 |
2 other studies available for cgp 52411 and Breast Neoplasms
| Article | Year |
|---|---|
A shift from normal to high glucose levels stimulates cell proliferation in drug sensitive MCF-7 human breast cancer cells but not in multidrug resistant MCF-7/ADR cells which overproduce PKC-betaII.
Topics: Blotting, Western; Breast Neoplasms; Cell Division; DNA; Dose-Response Relationship, Drug; Drug Resi | 1999 |
Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Division; Enzyme In | 2001 |